Edward J. Sitar

Overview

Edward J. Sitar received an average of $802K in total compensation, including $275K in salary, at 9 METERS BIOPHARMA from 2019 to 2021. Edward Sitar also received an average of $830K at Cancer Genetics between 2014 and 2015.

Source: SEC filings on May 13, 2022, May 12, 2021, and September 12, 2016.

Related executives

We found 12 more executives who work or worked at 9 METERS BIOPHARMA and Cancer Genetics.

John Temperato

9 METERS BIOPHARMA

Chief Executive Officer

John Roberts

Cancer Genetics

Chief Executive Officer

Yung-Ping Yeh

Cancer Genetics

Chief Information Officer

Ralf Brandt

Cancer Genetics

President, Discovery & Early Development Services

Andrew LaFrence

Cancer Genetics

Chief Financial Officer

Patrick FACP

9 METERS BIOPHARMA

Chief Medical Officer

Sandeep Laumas

9 METERS BIOPHARMA

Chief Executive Officer

Jay Madan

9 METERS BIOPHARMA

President and Chief Business Officer

News

You may also like